DXCM's Q3 results are likely to benefit from rising G7 use, early Stelo traction and expanding access across Type 2 diabetes ...
TipRanks on MSN
Hunterbrook Capital short DexCom, Hunterbrook Media reports
T hree people with diabetes died following use of Dexcom’s G7 continuous glucose monitor, according to Hunterbrook Media, ...
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired DexCom, Inc. ("DexCom" or the "Company") (NASDAQ:DXCM) securities during ...
ViCentra announced today that it appointed former Dexcom and Medtronic Diabetes leaders to new executive roles.
Dexcom faces new FDA reports linking its G7 glucose monitor to patient deaths as lawsuits and regulatory scrutiny intensify.
TipRanks on MSN
DexCom down 2% to $68.93 after Hunterbrook short report
EDT DexCom (DXCM) down 2% to $68.93 after Hunterbrook short report Published first on TheFly – the ultimate source for real-time, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback